 CAMBRIDGE, Mass.--BUSINESS WIRE--VBI Vaccines Inc. Nasdaq: VBIV VBI or the Company, a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the voting results from its annual general meeting of shareholders held on June 9, 2021 the Meeting. The total number of common shares of the Company Common Shares represented by shareholders Shareholders present in person or represented by proxy at the Meeting wa 